… lung function and trends toward improved … current recommendations and recent developments
in asthma management; it also considers the role of anticholinergic therapy and the future …

… β 2 /β 1 -selectivity of the compounds in the present study was given by the pEC 50 at the β 2
-adrenoceptor minus the pEC 50 at the β 1 -adrenoceptor. … investigated in the present study. …

… the present study, we investigated the effect of the β-AR agonist isoprenaline (ISO) on the
function of DCs, the impact of the β 2 -AR agonist … may be a direction for future research on RA. …

… adrenergic action in breast cancer is controversial. We have previously shown that β-adrenergic
agonists … Objective: The purpose of the present investigation was to evaluate adrenergic …

… adrenoceptor agonist) appears to be acceptable at therapeutic doses and comparable with
that of antimuscarinic agents, the current … analyzed in a detailed prospective analysis of the …

… , the concentrations used in previous studies were 100nM of salmeterol [29], 10nM aclidinium
[9] and 1nM of fluticasone propionate respectively, higher than those used in the present …

… Despite the fact that there is still very limited evidence for the physiological role of nicotinic
receptors in mammals, these receptors will not be considered in this review. The muscarinic …

… We herein present the stereospecific synthesis of covalently … on the pharmacophores of
adrenergic β 1 - and β 2 receptor … future structural and functional studies on the β 1 AR and β 2 …

… Citation 4 In many patients, the disease can be controlled by a combination of nonspecific
drugs, an inhaled corticosteroid (ICS) and a short- or long-acting β 2 -adrenergic agonist (…

… Here we present first steps to introduce a recently identified aptamer [15] new named BC007,
for binding and neutralizing of all the GPCR-AABs presently known as pathogenic drivers …